Innovacell GmbH

Pelvic Floor Disorders

Research activity is centered on fecal incontinence in female and male patients, with attention to conditions affecting continence control and daily function.

  • Fecal incontinence
  • Pelvic floor dysfunction
  • Continence impairment

The clinical focus includes patients with compromised bowel control linked to external anal sphincter dysfunction.

Anal Sphincter Dysfunction

The sponsor is involved in studies addressing external anal sphincter disruption and weakness, reflecting interest in structural and functional causes of incontinence.

  • External anal sphincter disruption
  • External anal sphincter weakness
  • Anal continence

Clinical interest extends to restoring sphincter-related control in patients whose symptoms arise from impaired muscle function.

Rehabilitative Gastroenterology

Therapeutic interest includes interventions aimed at improving bowel control in gastrointestinal and colorectal care settings.

  • Gastrointestinal disorders
  • Colorectal disorders
  • Bowel control

This area aligns with treatment needs for patients experiencing persistent incontinence symptoms requiring targeted clinical management.

Clinical Evaluation of Therapeutic Safety and Efficacy

Research activity includes assessment of clinical efficacy and clinical safety for therapies intended for fecal incontinence, with emphasis on patient outcomes in real-world clinical care.

  • Therapeutic efficacy
  • Therapeutic safety
  • Patient-centered outcomes

The sponsor’s trial portfolio involves multicountry clinical activity across several research sites focused on continence-related treatment.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on ICEF15 for Treating Fecal Incontinence in Patients with Anal Sphincter Dysfunction

    Recruiting

    1 1 1
    Investigated drugs:
    Austria Bulgaria Czechia France Germany Italy +4